Sandro Wealth Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.3M Hold
90,130
– – 2.13% 10
2026
Q2
$3.19M Buy
90,130
+838
+0.9% +$24.8K 2.3% 13
2026
Q1
$2.47M Sell
89,292
-975
-1% -$25K 1.98% 15
2025
Q4
$1.96M Buy
+90,267
New +$1.78M 1.62% 20

Other funds holding ROIV

Sandro Wealth Management's ROIV Position: Q3 2026 in Review

Sandro Wealth Management held its Roivant Sciences (ROIV) position steady in Q3 2026 at 90,130 shares worth $3.3M. The position accounts for 2.13% of the portfolio, ranked #10.

Sandro Wealth Management first reported a position in ROIV in Q4 2025 and has held it in 4 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Sandro Wealth Management held 90,130 shares of Roivant Sciences worth $3.3M as of Q3 2026.
  • Sandro Wealth Management left its Roivant Sciences share count unchanged in Q3 2026.
  • Roivant Sciences made up 2.13% of Sandro Wealth Management's portfolio in Q3 2026, its #10 holding.
  • Sandro Wealth Management first reported a position in Roivant Sciences in Q4 2025 and has held it in 4 quarters since.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Sandro Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.